American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network
Lead: Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network
Lead: Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network
Tuesday 17th October 2023
Dive into ASAM's latest research on common brain networks in addiction, risk prediction, anti-craving meds, fentanyl prevalence, and policy impacts.
6 minutes
Informative
Empowering
Hopeful
Educational
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
140 (View all)
Do you want to link to this podcast?
Get the buttons here!Brain Networks and Addiction: Fresh Insights from ASAM's Latest Research
Episode Overview
- Neuroimaging study reveals common brain network specific to substance use disorders
- Prediction tool formulated for return to use during opioid use disorder treatment
- Evaluation of anti-craving medications for alcohol use disorder in emergency departments
- Study on prevalence of fentanyl in methamphetamine and cocaine samples
- Outcomes of non-medical cannabis legalization policy in Canada
Researchers found that 91% of the neuroimaging findings did map to a common brain network specific to substance use disorders when compared to atrophy associated with normal aging and neurodegenerative disease.
Ever wondered how different substances affect the brain in similar ways? This episode of 'Addiction Medicine Unpacked' dives into groundbreaking research revealing that neuroimaging findings across various substance use disorders point to a common brain network. By analyzing data from 45 studies on brain atrophy and 99 studies on functional MRI abnormalities, researchers discovered that these abnormalities map to a similar brain network regardless of the substance involved.
This could mean big things for understanding and treating addiction on a broader scale. But that's not all you'll get in this episode. It also covers fascinating topics like individual risk prediction during opioid use disorder treatment and the effectiveness of anti-craving medications for alcohol use disorder. Plus, there's a deep dive into the prevalence of fentanyl in methamphetamine and cocaine samples, and the presence of synthetic cooling agents in non-menthol cigarettes post-menthol ban.
If you think that's all, think again! The episode also explores innovative solutions like optimizing drone networks to respond to opioid overdoses and discusses how addiction medicine specialists can guide the effective spending of opioid settlements. And for those interested in policy outcomes, there's an examination of the impacts of non-medical cannabis legalization in Canada. This episode is a treasure trove of insights for healthcare professionals, students, or anyone touched by addiction.
Don't miss out on these essential updates from the field of addiction medicine.